|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2004-10-12
|
|
pubmed:abstractText |
Although alemtuzumab (campath-1H) has been successfully used in patients with untreated or previously treated chronic lymphocytic leukemia (CLL), a variable incidence of cytomegalovirus (CMV) reactivation has been described. No prospective reports currently provide results of the use of oral ganciclovir as pre-emptive therapy in patients with CMV reactivation during alemtuzumab treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Ganciclovir,
http://linkedlifedata.com/resource/pubmed/chemical/alemtuzumab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1592-8721
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1248-52
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15477211-Administration, Oral,
pubmed-meshheading:15477211-Aged,
pubmed-meshheading:15477211-Antibodies, Monoclonal,
pubmed-meshheading:15477211-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:15477211-Antibodies, Neoplasm,
pubmed-meshheading:15477211-Antigens, Viral,
pubmed-meshheading:15477211-Antiviral Agents,
pubmed-meshheading:15477211-Cytomegalovirus,
pubmed-meshheading:15477211-Cytomegalovirus Infections,
pubmed-meshheading:15477211-Female,
pubmed-meshheading:15477211-Ganciclovir,
pubmed-meshheading:15477211-Humans,
pubmed-meshheading:15477211-Immunotherapy,
pubmed-meshheading:15477211-Incidence,
pubmed-meshheading:15477211-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:15477211-Male,
pubmed-meshheading:15477211-Middle Aged,
pubmed-meshheading:15477211-Prospective Studies,
pubmed-meshheading:15477211-Viremia,
pubmed-meshheading:15477211-Virus Activation
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir.
|
|
pubmed:affiliation |
Divisione di Ematologia, Istituto di Ematologia, Universita' Cattolica Sacro Cuore, Largo A. Gemelli, 8 00168 Roma, Italia.emacat@rm.unicatt.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
